CNS vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

59.9
AI Score
VS
HLNE Wins

HLNE

68.2
AI Score

Investment Advisor Scores

CNS

Oct 02, 2026
60score
Recommendation
HOLD

HLNE

Oct 02, 2026
68score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS HLNE Winner
Forward P/E 18.4502 12.0192 HLNE
PEG Ratio 1.6881 1.39 HLNE
Revenue Growth 12.2% 56.5% HLNE
Earnings Growth 31.9% 50.5% HLNE
Tradestie Score 59.9/100 68.2/100 HLNE
Profit Margin 28.8% 32.1% HLNE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% HLNE 1M: -14.0% · 3M: +11.0%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

HLNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.0 · Price: $88.57

Fundamentals Snapshot

Metric CNS HLNE
Market Cap — —
Forward P/E 18.4 14.8
Trailing P/E 22.4 13.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.5% 0.6%
Operating Margin 0.3% 0.5%
EPS 3.26 6.57
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, HLNE is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.